FROM Kevin Davies
Genome Companies Dominate the Southland Last week, we talked about the development of genome sequencing , which took 10 years and $2 billion twenty years ago. Since then, it’s developed at an astonishing pace, centered in Southern California. Kevin Davies is editor-in-chief of Bio-IT World and author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
The $1,000 Genome and 'Personalized Medicine' It took $2 billion and ten years to complete the Human Genome Project . Now, just ten years later, many individuals have had their genomes sequenced, and the cost keeps dropping. Kevin Davies is editor of Bio-IT World , which covers the role of technology in the life sciences. He's also the author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
White House budget proposal slashes and burns President Trump's first budget request is considered dead on arrival in Congress — a familiar development in Capitol Hill. We hear what it reveals about the priorities of the new administration. What's likely to die… and what might survive?
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
Terrorism and tweets, hate speech and murder Just days before an election, Britain is coping with a rash of deadly terrorism, and Prime Minister Theresa May is on the defensive. And again today, President Trump has tweeted criticism of the Mayor of London. Later, a double murder in Portland, Oregon has revealed the ugly past of a supposedly “progressive” city. One immediate question: is “hate speech” protected by the First Amendment?
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.